American Academy of Neurology (AAN) Clinical Updates on Novel Receptor Modulator Therapeutics for the Management of Patients with Relapsing Multiple Sclerosis
WebcastFaculty
OVERVIEW
American Academy of Neurology (AAN) Clinical Updates on Novel Receptor Modulator Therapeutics for the Management of Patients with Relapsing Multiple Sclerosis is organized by Academic CME and will be held during Jun 12, 2017 - Jun 11, 2018.
The target audience for this medical event is Neurologists, primary care physicians and other healthcare professionals responsible for the management of patients with MS. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Review diagnostic criteria and prognosis of multiple sclerosis, including the role of immune-inflammation in relapsing disease.
• Analyze clinical trial data of emerging receptor modulator therapeutics for the treatment of relapsing multiple sclerosis presented at AAN 2017.
• Apply recent science into individualized treatment plans to improve outcomes for patients with relapsing multiple sclerosis.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Neurologists, primary care physicians and other healthcare professionals responsible for the management of patients with MS. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Review diagnostic criteria and prognosis of multiple sclerosis, including the role of immune-inflammation in relapsing disease.
• Analyze clinical trial data of emerging receptor modulator therapeutics for the treatment of relapsing multiple sclerosis presented at AAN 2017.
• Apply recent science into individualized treatment plans to improve outcomes for patients with relapsing multiple sclerosis.
Additional details will be posted as soon as they are available.
SPECIALITIES
Neurology
Quick Links